Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions
Alyssa Duffy, … , Madhav V. Dhodapkar, Kavita M. Dhodapkar
Alyssa Duffy, … , Madhav V. Dhodapkar, Kavita M. Dhodapkar
Published May 2, 2024
Citation Information: J Clin Invest. 2024;134(12):e174724. https://doi.org/10.1172/JCI174724.
View: Text | PDF
Research Letter Immunology Oncology Article has an altmetric score of 6

Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions

  • Text
  • PDF
Abstract

Authors

Alyssa Duffy, Maryam I. Azeem, Smriti Kanangat, Melinda Yushak, David Lawson, Madhav V. Dhodapkar, Kavita M. Dhodapkar

×

Figure 1

Mechanisms of T/B interactions.

Options: View larger image (or click on image) Download as PowerPoint
Mechanisms of T/B interactions.
(A–C) T/B cocultures. Purified B cells w...
(A–C) T/B cocultures. Purified B cells were cultured alone or with flow-sorted ICOS+CD4+ and ICOS–CD4+ T cells from patients with melanoma after CCB treatment (Supplemental Methods). (A) Representative flow plot of CD38+CD27+ plasmablast. (B) Human IgG levels by ELISA (n = 9). Kruskal-Wallis with Dunn’s multiple comparisons correction. (C) Effect of B cell subsets. Flow-sorted posttreatment T cells were cultured with memory(n = 5) or naive B cells (n = 6). Bar graphs indicate fold change compared with cultures with B cells alone. One-way ANOVA with Tukey’s multiple test correction. (D–F) Human T/B interactions in vivo. Sorted ICOS+CD4+ or ICOS–CD4+ T cells from patients with melanoma (n = 5) were injected into MISTRG6 mice along with purified human B cells (Supplemental Methods). (D) Representative flow plots of plasmablast frequency in the spleen at 2 weeks after injection, as quantified in E. One-way ANOVA with Dunn’s multiple correction. (F) Human IgG levels detected by ELISA in mice from E. Wilcoxon’s matched-pairs signed-rank test. (G) Bar graph shows expansion of ICOS+CD4+ T cells after CCB therapy in patients with no HG-irAEs and those with HG-irAEs. Wilcoxon’s matched-pairs rank test. (H) B cells were cultured with flow-sorted ICOS+CD4+ and ICOS–CD4+ T cells from patients with HG-irAEs or no HG-irAEs. Bar graph shows fold change in plasmablasts in ICOS+ versus ICOS– cocultures. Mann-Whitney. (I) FlowSOM performed on ICOS+CD4+ T cells obtained following 1 cycle of combination therapy identified 10 metaclusters (MCs). Bar graph shows proportions of these MCs in patients with HG-irAEs or no HG-irAEs. Mann-Whitney. (J) Depletion of Tregs in patients with no HG-irAEs leads to enhanced B cell activation by ICOS+CD4+ T cells. Purified B cells were cultured with ICOS–, bulk ICOS+, or Treg-depleted ICOS+CD4+ T cells from patients with no HG-irAEs. Dot plot shows plasmablast frequency as percentage of B cells. Bar graph shows data for 7 different experiments. Wilcoxon’s matched-pairs rank test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 7 X users
3 readers on Mendeley
See more details